Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic

Patients with substance use disorders (SUD) are at increased risk of both coronavirus disease-19 complications as well as exacerbations of their current conditions due to social distancing and isolation. Innovations that provide increased access to support substance use disorder patients may mitigat...

Full description

Bibliographic Details
Main Authors: Jill S. Warrington MD, PhD, Alexa Brett BAS, Heather Foster, Jamie Brandon BA, Samuel Francis-Fath BS, Michael Joseph BS, Mark Fung MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2020-09-01
Series:Academic Pathology
Online Access:https://doi.org/10.1177/2374289520953557
id doaj-d8c156b924964ed6bc9c59fc90bb5fc3
record_format Article
spelling doaj-d8c156b924964ed6bc9c59fc90bb5fc32020-11-25T03:33:03ZengSAGE PublishingAcademic Pathology2374-28952020-09-01710.1177/2374289520953557Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) PandemicJill S. Warrington MD, PhD0Alexa Brett BAS1Heather Foster2Jamie Brandon BA3Samuel Francis-Fath BS4Michael Joseph BS5Mark Fung MD, PhD6 Department of Pathology and Laboratory Medicine, Robert Larner College of Medicine, , VT, USA Aspenti Health, South Burlington, VT, USA Aspenti Health, South Burlington, VT, USA Aspenti Health, South Burlington, VT, USA Aspenti Health, South Burlington, VT, USA True Vector Management Consulting, Milton, VT, USA Department of Pathology and Laboratory Medicine, Robert Larner College of Medicine, , VT, USAPatients with substance use disorders (SUD) are at increased risk of both coronavirus disease-19 complications as well as exacerbations of their current conditions due to social distancing and isolation. Innovations that provide increased access to support substance use disorder patients may mitigate long-term sequelae associated with continued or renewed drug use. To improve patient access during the coronavirus disease-19 pandemic, we deployed a mobile unit to enable access to urine drug testing where needed for patients suffering from substance use disorder. Over a 3-week pilot program, 54 patients received urine drug testing across 5 providers and 8 zip codes. The mobile unit was cost-effective, demonstrating a volume-dependent 19% lower cost compared to pre-coronavirus disease-19 patient service centers in a similar geographic region. The mobile unit was well-received by patients and providers with an average of 9 out of 10 satisfaction scores and allowed for access to urine drug testing for 67% patients who would not have received testing during this time frame. No statistically significant differences were found in substance use positivity rates in comparison to pre-coronavirus disease findings; however, some shifts in use included higher rates of fentanyl and opioid positivity and reductions in tetrahydrocannabinol and cocaine use in the mobile collections setting. Deployment of mobile collection services during the coronavirus disease-19 pandemic has shown to be an effective mechanism for supporting patients suffering from substance use disorder, allowing for access to care of this often stigmatized, vulnerable population.https://doi.org/10.1177/2374289520953557
collection DOAJ
language English
format Article
sources DOAJ
author Jill S. Warrington MD, PhD
Alexa Brett BAS
Heather Foster
Jamie Brandon BA
Samuel Francis-Fath BS
Michael Joseph BS
Mark Fung MD, PhD
spellingShingle Jill S. Warrington MD, PhD
Alexa Brett BAS
Heather Foster
Jamie Brandon BA
Samuel Francis-Fath BS
Michael Joseph BS
Mark Fung MD, PhD
Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic
Academic Pathology
author_facet Jill S. Warrington MD, PhD
Alexa Brett BAS
Heather Foster
Jamie Brandon BA
Samuel Francis-Fath BS
Michael Joseph BS
Mark Fung MD, PhD
author_sort Jill S. Warrington MD, PhD
title Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic
title_short Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic
title_full Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic
title_fullStr Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic
title_full_unstemmed Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic
title_sort driving access to care: use of mobile units for urine specimen collection during the coronavirus disease-19 (covid-19) pandemic
publisher SAGE Publishing
series Academic Pathology
issn 2374-2895
publishDate 2020-09-01
description Patients with substance use disorders (SUD) are at increased risk of both coronavirus disease-19 complications as well as exacerbations of their current conditions due to social distancing and isolation. Innovations that provide increased access to support substance use disorder patients may mitigate long-term sequelae associated with continued or renewed drug use. To improve patient access during the coronavirus disease-19 pandemic, we deployed a mobile unit to enable access to urine drug testing where needed for patients suffering from substance use disorder. Over a 3-week pilot program, 54 patients received urine drug testing across 5 providers and 8 zip codes. The mobile unit was cost-effective, demonstrating a volume-dependent 19% lower cost compared to pre-coronavirus disease-19 patient service centers in a similar geographic region. The mobile unit was well-received by patients and providers with an average of 9 out of 10 satisfaction scores and allowed for access to urine drug testing for 67% patients who would not have received testing during this time frame. No statistically significant differences were found in substance use positivity rates in comparison to pre-coronavirus disease findings; however, some shifts in use included higher rates of fentanyl and opioid positivity and reductions in tetrahydrocannabinol and cocaine use in the mobile collections setting. Deployment of mobile collection services during the coronavirus disease-19 pandemic has shown to be an effective mechanism for supporting patients suffering from substance use disorder, allowing for access to care of this often stigmatized, vulnerable population.
url https://doi.org/10.1177/2374289520953557
work_keys_str_mv AT jillswarringtonmdphd drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic
AT alexabrettbas drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic
AT heatherfoster drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic
AT jamiebrandonba drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic
AT samuelfrancisfathbs drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic
AT michaeljosephbs drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic
AT markfungmdphd drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic
_version_ 1724565070298480640